Overview

A Safety and Tolerability Study OF PUR118 In Subjects With Cystic Fibrosis

Status:
Completed
Trial end date:
2012-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether PUR118 is safe and tolerable in a population of subjects with Cystic Fibrosis.
Phase:
Phase 1
Details
Lead Sponsor:
Pulmatrix Inc.
Collaborator:
Celerion